The coexistence of neuropathic pain, sleep, and psychiatric disorders : A novel treatment approach

Clinical Journal of Pain

Volumn 23, Issue 1, 2007, Pages 15-22

  Argoff, Charles E ^a,b  

^a North Shore LIJ Health System   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anticonvulsants; Antidepressants; Comorbidities; Mood disorders; Neuropathic pain; Sleep disturbance

Indexed keywords

ANXIETY DISORDER; DEPRESSION; HUMAN; MENTAL DISEASE; NEURALGIA; PATHOPHYSIOLOGY; QUALITY OF LIFE; REVIEW; SLEEP DISORDER;

ANXIETY DISORDERS; DEPRESSION; HUMANS; MENTAL DISORDERS; NEURALGIA; QUALITY OF LIFE; SLEEP DISORDERS;

EID: 33847310931     PISSN: 07498047     EISSN: 15365409     Source Type: Journal    
DOI: 10.1097/01.ajp.0000210945.27052.b3     Document Type: Article

References (81)

1. Merskey H, ed. Prepared by the IASP Subcommittee on Taxonomy. Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms. Pain. 1986;3:S1-S226.
2. Bennett GJ. Neuropathic pain: an overview. In: Borsook D, ed. Progress in Pain Research and Management. Vol. 9. Seattle: IASP Press; 1997:109-113.
3. Burstein R, Cutrer MF, Yarnitksy D. The development of cutaneous allodynia during a migraine attack. Clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine. Brain. 2000;123:1703-1709.
4. Russell IJ. Advances in fibromyalgia: possible role for central neurochemicals. Am J Med Sci. 1998;315:377-384.
5. Lipton RB, Stewart WF, Diamond S, et al. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache. 2001;41:646-657.
6. Wolfe R, Ross K, Anderson J, et al. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum. 1995;38:19-28.
7. Fishbain DA. Approaches to treatment decisions for psychiatric comorbidity in the management of the chronic pain patient. Med Clin North Am. 1999;83:737-760.
8. Smith MT, Perlis ML, Smith MS, et al. Sleep quality and presleep arousal in chronic pain. J Behav Med. 2000;23:1-13.
9. Chalkiadis GA. Management of chronic pain in children. Med J Aust. 2001;175:476-479.
10. Morin CM, Gibson D. Wade J. Self-reported sleep and mood disturbance in chronic pain patients. Clin J Pain. 1998;14:311-314.
11. Meyer-Rosberg K, Burckhardt CS, Huizar K, et al. A comparison of the SF-36 and Nottingham Health Profile in patients with chronic neuropathic pain. Eur J Pain. 2001;5:391-403.
12. Meyer-Rosberg K, Kvarnstrom A, Kinnman E, et al. Peripheral neuropthaic pain - a multidimensional burden for patients. Eur J Pain. 2001;5:379-389.
13. Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore. 1994;23:129-138.
14. Kerns RD, Turk DC, Rudy TE. The West Haven-Yale Multidimensional Pain Inventory (WHYMPI). Pain. 1985;23:345-356.
15. Roth T, Roehrs T. Sleep organization and regulation. Neurology. 2000;54(suppl 1):S2-S7.
16. Widerstrom-Noga EG, Felipe-Cuervo E, Yezierski RP. Chronic pain after spinal injury: interference with sleep and daily activities. Arch Phys Med Rehabil. 2001;82:1571-1577.
17. Galer BS, Henderson J, Perander J, et al. Course of symptoms and quality of life measurement in Complex Regional Pain Syndrome: a pilot survey. J Pain Symptom Manage. 2000;20:286-292.
18. Galer BS, Gianas A, Jensen MP. Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life. Diabetes Res Clin Pract. 2000;47:123-128.
19. Chokroverty S. Diagnosis and treatment of sleep disorders caused by comorbid disease. Neurology. 2000;54(suppl 1):S8-S15.
20. Kalso E, Mennander S, Tasmuth T, et al. Chronic post-sternotomy pain. Acta Anaesthesiol Scand. 2001;45:935-939.
21. Folmer RL, Griest SE, Martin WH. Chronic tinnitus as phantom auditory pain. Otolaryngol Head Neck Surg. 2001;124:394-400.
22. National Center on Sleep Disorders Research Working Group. Insomnia: assessment and management in primary care. Sleep. 1999;22(suppl 2):S402-S408.
23. National Center on Sleep Disorders Research Working Group. Recognizing problem sleepiness in your patients. Am Fam Phys. 1999;59:937-944.
24. Buysse DJ, Reynolds CF III, Monk TH, et al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193-213.
25. Backhaus J, Junghanns K, Broocks A, et al. Test-retest reliability and validity of the Pittsburgh Sleep Quality Index in primary insomnia. J Psychosom Res. 2002;53:737-740.
26. Johns MW. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep. 1991;14:540-545.
27. Douglass AB, Bornstein R, Nino-Murcia G, et al. The sleep disorders questionnaire. I: Creation and multivariate structure of SDQ. Sleep. 1994;17:160-167.
28. Chesson A Jr, Hartse K, Anderson WM, et al. Practice parameters for the evaluation of chronic insomnia. An American Academy of Sleep Medicine report. Standards of Practice Committee of the American Academy of Sleep Medicine. Sleep. 2000;23:237-241.
29. NIH Technology Assessment Panel on Integration of Behavioral and Relaxation Approaches into the Treatment of Chronic Pain and Insomnia. Integration of behavioral and relaxation approaches into the treatment of chronic pain and insomnia. JAMA. 1996; 276:313-318.
30. Smith MT, Haythornthwaite JA. How do sleep disturbance and chronic pain inter-relate? Insights from the longitudinal and cognitive-behavioral clinical trials literature. Sleep Med Rev. 2004;8:119-132.
31. Morin CM, Kowatch RA, Wade JB. Behavioral management of sleep disturbances secondary to chronic pain. J Behav Ther Exp Psychiatr. 1989;20:295-302.
32. Kingery WS. A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes. Pain. 1997;73:123-139.
33. Sindrup SH, Gram LF, Skjold T, et al. Clomipramine vs. desipramine vs. placebo in the treatment of diabetic neuropathy symptoms. A double-blind cross-over study. Br J Clin Pharmacol. 1990;30:683-691.
34. Doghramji K. Psychiatry clinical management, volume 2. Sleepless in America - diagnosing and treating insomnia. Medscape 2000. Available at: http://www.medscape.com/medscape/psychiatry/ClinicalMgmt/CM.v02/CM.v02-01.html
35. Sindrup SH, Gram LF, Brosen K, et al. The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain. 1990;42:135-144.
36. Sindrup SH, Bjerre U, Dejgaard A, et al. The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy. Clin Pharmacol Ther. 1992;52:547-552.
37. Pernia A, Micó J-A, Calderón E, et al. Venlafaxine for the treatment of neuropathic pain. J Pain Symptom Manage. 2000;19: 408-410.
38. Goldstein DJ, Lu Y, Detke MJ, et al. Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain. 2005;116: 109-118.
39. Thase ME. Antidepressant treatment of the depressed patient with insomnia. J Clin Psychiatry. 1999;267:548-551.
40. Chalon S, Pereira A, Lainey E, et al. Comparative effects of duloxetine and desipramine on sleep EEG in healthy subjects. Psychopharmacology (Berlin). 2005;177:357-365.
41. McQuay HJ, Tramér M, Nye BA, et al. A systematic review of antidepressants in neuropathic pain. Pain. 1996;68:217-227.
42. Baldessarini RJ. Drugs and the treatment of psychiatric disorders: depression and mania. In: Hardman JG, Gilman AG, Limbird LE, eds. Goodman & Gilman's The Pharmacological Basis of Therapeutics. 9th ed. New York: McGraw-Hill; 1995:431-459.
43. Blom S. Trigeminal neuralgia: its treatment with a new anticonvulsant drug (G-32883). Lancet. 1962;1:839-840.
44. Rowbotham M, Harden N, Stacey B, et al. Gabapentin for the treatment of post-herpetic neuralgia: a multicenter, double-blind, placebo-controlled study. JAMA. 1998;280:1837-1842.
45. Backonja M, Beydoun A, Edwards KR, et al. Gabapentin monotherapy for the treatment of painful neuropathy: a multicenter, double-blind, placebo-controlled trial in patients with diabetes mellitus. JAMA. 1998;280:1831-1836.
46. Rice AS, Maton S. Response to Comment on Rice ASC, Maton S, the Postherpetic Neuralgia Study Group (UK). Gabapentin in postherpetic neuralgia: a randomized, double blind, placebocontrolled study. Pain. 2001;94:215-224.
47. Kubota T, Fang J, Meltzer LT, et al. Pregabalin enhances nonrapid eye movement sleep. J Pharmacol Exp Ther. 2001;299:1095-1105.
48. Hindmarch I, Dawson J, Stanley N. A double-blind study in healthy volunteers to assess effects on sleep of pregabalin compared with alprazolam and placebo. Sleep. 2005;28:187-193.
49. Dworkin RH, Corbin AE, Young JP Jr, et al. Pregabalin for the treatment of postherpetic neuralgia. A randomized, placebocontrolled trial. Neurology. 2003;60:1274-1283.
50. Sabatowski R, Gálvez R, Cherry DA, et al. Pregabalin reduces pain and improves sleep and mood disturbances in patients with postherpetic neuralgia: results of a randomized, placebo-controlled trial. Pain. 2004;109:26-35.
51. Rosenstock J, Tuchman M, LaMoreaux L, et al. Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. Pain. 2004;110:628-638.
52. Lesser H, Sharma U, LaMoreaux L, et al. Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial. Neurology. 2004;63:2104-2110.
53. Richter RW, Portenoy R, Sharma U, et al. Relief of painful diabetic neuropathy with pregabalin: a randomized, placebo-controlled trial. J Pain. 2005;6:253-260.
54. Freynhagen R, Strojek K, Griesing T, et al. Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomized, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens. Pain. 2005;115:254-263.
55. Koenig TW, Clark MR. Advances in comprehensive pain management. Psychiatric Clin North Am. 1996;19:589-611.
56. Eisendrath SJ. Psychiatric aspects of chronic pain. Neurology. 1995;45(suppl 9):S26-S34.
57. Romano JM, Turner JA. Chronic pain and depression: does the evidence support a relationship? Psychol Bull. 1985;97:18-34.
58. Rodin G, Voshart K. Depression in the medically ill: an overview. Am J Psychiatry. 1986;143:696-705.
59. Fishbain DA, Cutler R, Rosomoff HL, et al. Chronic painassociated depression: antecedent or consequence of chronic pain? A review. Clin J Pain. 1997;13:116-137.
60. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000.
61. Angst J. Depression and anxiety: implications for nosology, course, and treatment. J Clin Psychiatry. 1997;58(suppl 8):3-5.
62. Kremer E, Atkinson JH, Fagnelzi RN. Measurement of pain: patient preference does not confound pain measurement. Pain. 1981; 51:281-287.
63. Cornwall A, Doncleri DC. The effect of experimentally induced anxiety on the experience of pressure pain. Pain. 1988;35:105-113.
64. Polatin PD, Kinney RK, Gatchel RJ, et al. Psychiatric illness and chronic low-back pain. Spine. 1993;18:66-71.
65. Willoughby SG, Hailey BJ, Wheeler LC. Pain Patient Profile: a scale to measure psychological distress. Arch Phys Med Rehabil. 1999;80: 1300-1302.
66. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatr. 1960;23:56-62.
67. Maier W, Buller R, Philipp M, et al. The Hamilton Anxiety Scale: reliability, validity and sensitivity to change in anxiety and depressive disorders. J Affect Disord. 1988;14:61-68.
68. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:53-63.
69. Davidson J, Turnbull CD, Strickland R, et al. The Montgomery- Åsberg Depression Scale: reliability and validity. Acta Psychiatr Scand. 1986;73:544-548.
70. Pollock V, Cho DW, Reker D, et al. Profile of mood states: the factors and their physiological correlates. J Nerv Ment Dis. 1979; 167:612-614.
71. Derogatis LR, Lipman RS, Rickels K, et al. The Hopkins Symptoms Checklist (HSCL): a self-report symptom inventory. Behav Sci. 1974;19:1-15.
72. Zung WWK. A self-rating depression scale. Arch Gen Psychiatry. 1965;12:63-70.
73. Zung WWK. A rating instrument for anxiety disorders. Psychosomatics. 1971;12:371-379.
74. Ahearn EP. The use of visual analog scales in mood disorders: a critical review. J Psychiatr Res. 1997;31:569-579.
75. Goldstein DJ, Lu Y, Detke MJ, et al. Duloxetine in the treatment of depression. A double-blind placebo-controlled comparison with paroxetine. J Clin Psychopharm. 2004;24:389-399.
76. Blacker D. Maintenance treatment of major depression: a review of the literature. Harv Rev Psychiatry. 1996;4:1-9.
77. Pollack MH, Matthews J, Scott EL. Gabapentin as a potential treatment for anxiety disorders. Am J Psychiatry. 1998;155: 992-993.
78. Pande AC, Crockatt JG, Feltner DE, et al. Pregabalin in generalized anxiety disorder: a placebo-controlled trial. Am J Psychiatry. 2003;160:533-540.
79. Feltner DE, Crockatt JG, Dubovsky SJ, et al. A randomized, double-blind, placebo-controlled, fixed-dose, multicenter study of pregabalin in patients with generalized anxiety disorder. J Clin Psychopharm. 2003;23:240-249.
80. Raja SN, Haythornthwaite JA. Combination therapy for neuropathic pain - which drugs, which combination, which patients? N Engl J Med. 2005;352:1373-1375.
81. Gilron I, Bailey JM, Tu D, et al. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med. 2005;352: 1324-1334.